Fotios Theodorou Toulgaridis

Dr. Fotios Theodorou Toulgaridis

Evangelismos Hospital, Athens, Attikí, Greece
orcid
Sismanogleio G.H. of Attica, Athens, Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
Fotios Theodorou ToulgaridisFotios Theodorou Toulgaridis
Fotios Theodorou Toulgaridis
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
Andreas KalogeropoulosAndreas Kalogeropoulos
Andreas Kalogeropoulos
GKGrigoris V. Karamasis
Grigoris V. Karamasis
PDPeriklis Davlouros
Periklis Davlouros
BACKGROUND: Coronary computed tomography angiography (CCTA) in patients with post–coronary artery bypass graft (CABG) has a high diagnostic accuracy for visualization of grafts. Invasive coronary angiography (ICA) in patients with CABG is associated with increased procedural time, contrast agent administration, radiation exposure, and complications, compared with non-CABG patients. The aim of this multicenter, randomized controlled trial was to compare the strategy of CCTA-guided ICA versus classic ICA in patients with prior CABG. METHODS: Patients with prior CABG were randomly assigned (1:1 ratio) to have a CCTA before ICA (CCTA-ICA, group A) or not (ICA-only, group B). The primary end point of the study was the total volume (milliliters) of the contrast agent administered. RESULTS: A total of 251 patients were randomized, and 225 were included in analysis; 110 in group A and 115 in group B. The total contrast volume was higher in group A (184.5 [143–255] versus 154 [102–240] mL; P =0.001). The contrast volume administered during the invasive procedure was lower in group A (101.5 [60–151] versus 154 [102–240]; P <0.001). Total fluoroscopy time was decreased in group A (480 [259–873] versus 594 [360–1080] seconds; P =0.027), but total effective dose was increased (24.1 [17.7–32] versus 10.8 [5.6–18] mSv; P <0.001). The rate of contrast-induced nephropathy, periprocedural complications, and major adverse cardiac events during 3 to 5 and 30 days did not differ significantly between the 2 groups. CONCLUSIONS: A CCTA-directed ICA strategy for patients with CABG is associated with expedition of the invasive procedure, and less fluoroscopy time, at the cost of higher total contrast volume and effective radiation dose, compared with the classic ICA approach. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04631809.

28 September 2022 in Life
Verified
Journal Article
Open access
PDF file
PPPanteleimon E. Papakonstantinou
Panteleimon E. Papakonstantinou
DBDIMITRA BENIA
DIMITRA BENIA
DPDimitrios Polyzos
Dimitrios Polyzos
KPKonstantinos Papakonstantinou
Konstantinos Papakonstantinou
FRFilippos - Paschalis Rorris
Filippos - Paschalis Rorris
ASAntonios Sideris
Antonios Sideris
Thoracic aortic dissection (AD) is associated with increased morbidity and mortality. Acute aortic syndrome is the first presentation of the disease in most cases. While acute AD management follows concrete guidelines because of its urgent and life-threatening nature, chronic AD is usually overlooked, although it concerns a wide spectrum of patients surviving an acute event. Acute AD survivors ultimately enter a chronic aortic disease course. Patients with chronic thoracic AD (CTAD) require lifelong surveillance and a proportion of them may present with symptoms and late complications demanding further surgical or endovascular treatment. However, the available data concerning the management of CTAD is sparse in the literature. The management of patients with CTAD is challenging as far as determining the best medical therapy and deciding on intervention are concerned. Until recently, there were no guidelines or recommendations for imaging surveillance in patients with chronic AD. The diagnostic methods for imaging aortic diseases have been improved, while the data on new endovascular and surgical approaches has increased significantly. In this review, we summarize the current evidence in the diagnosis and management of CTAD and the latest recommendations for the surgical/endovascular aortic repair of CTAD.

1 November 2021 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
ASAndreas Synetos
Andreas Synetos
George LatsiosGeorge Latsios
George Latsios
KTKonstantinos Toutouzas
Konstantinos Toutouzas
ESEleni Sertedaki
Eleni Sertedaki

12 January 2026 in Life
Verified
Journal Article
Open access
PDF file
Nikolaos TsiamisNikolaos Tsiamis
Nikolaos Tsiamis
DADimitrios Afendoulis
Dimitrios Afendoulis
CTChristos Tountas
Christos Tountas
Fotios Theodorou ToulgaridisFotios Theodorou Toulgaridis
Fotios Theodorou Toulgaridis
FTFlora Tsakirian
Flora Tsakirian
KTKonstantinos Tsioufis
Konstantinos Tsioufis
Background: Cardiac amyloidosis (CA) is characterized by progressive myocardial infiltration leading to restrictive cardiomyopathy and heart failure. While left ventricular assessment has traditionally dominated prognostic evaluation, right ventricular (RV) dysfunction and RV–pulmonary artery (PA) coupling have emerged as critical determinants of outcomes. Objectives: This review synthesizes current evidence on RV–PA coupling as a prognostic marker in cardiac amyloidosis, examining measurement methodologies, prognostic significance, pathophysiological mechanisms, and clinical applications. Methods: We comprehensively reviewed the recent literature on RV–PA coupling in CA, focusing on studies published from 2020 to 2025, including both AL and ATTR subtypes. We analyzed data from multicenter cohorts, prospective registries, and validation studies examining the relationship between RV–PA coupling indices and clinical outcomes. Results: RV–PA coupling, most commonly assessed using the tricuspid annular plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP) ratio, consistently demonstrates strong independent prognostic value for mortality and heart failure outcomes in CA patients. Impaired coupling (TAPSE/PASP < 0.45 mm/mmHg) identifies high-risk patients with hazard ratios ranging from 1.98 to 4.17 for adverse outcomes. In a multicenter cohort of 283 patients, TAPSE/PASP < 0.45 mm/mmHg was independently associated with death or heart failure hospitalization (HR 1.98, 95% CI 1.32–2.96, p = 0.001) and significantly improved risk reclassification (NRI 0.46–0.49). In ATTR-specific populations receiving disease-modifying therapy, impaired coupling (TAPSE/PASP ≤ 0.382 mm/mmHg) predicted three-year mortality with an adjusted HR of 2.99. The coupling index provides incremental value over individual RV parameters by accounting for afterload conditions and demonstrates consistent prognostic performance across both AL and ATTR subtypes. Conclusions: RV–PA coupling represents a robust, easily obtainable prognostic marker that should be routinely assessed in CA patients for risk stratification and clinical decision-making. The TAPSE/PASP ratio can be calculated from standard echocardiographic examinations without additional cost or time, making it practical for widespread implementation. Future research should focus on standardizing measurement protocols, establishing disease-specific thresholds, evaluating coupling trajectories with novel therapies, and integrating coupling assessment into staging systems and management algorithms. The strong prognostic signal, pathophysiological relevance, and ease of measurement position RV–PA coupling as an essential component of comprehensive cardiac amyloidosis evaluation.

1 July 2026 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Nikolaos TsiamisNikolaos Tsiamis
Nikolaos Tsiamis
Fotios Theodorou ToulgaridisFotios Theodorou Toulgaridis
Fotios Theodorou Toulgaridis
ESEleni Stefanou
Eleni Stefanou
CTChristos Tountas
Christos Tountas
GTGeorgios Tsitsinakis
Georgios Tsitsinakis
Christo KOLEChristo KOLE
Christo KOLE

24 May 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
ASAthanasios Saplaouras
Athanasios Saplaouras
KVKonstantinos Vlachos
Konstantinos Vlachos
PMPanagiotis Mililis
Panagiotis Mililis
ABA Batsouli
A Batsouli
George BazoukisGeorge Bazoukis
George Bazoukis
KLKonstantinos Letsas
Konstantinos Letsas
Objectives: The study sought to evaluate the impact of the stricter Strauss criteria for left bundle branch block (St-LBBB) on cardiac resynchronization therapy (CRT) response, hospitalizations, ventricular arrhythmia (VA) events and mortality. Background: Although left bundle branch block (LBBB) is a strong predictor of response to CRT, a significant number of patients remain non-responders. Methods: This is a retrospective analysis of prospectively collected data on heart failure (HF) patients with LBBB admitted for CRT implantation. Patients were divided in two groups according to the fulfillment or not of St-LBBB criteria. Results: 82 patients with ischemic (ICM) and non-ischemic (NICM) HF [46 (56%) with St-LBBB and 36 (44%) with non-St-LBBB] were included. CRT response was more likely to occur in patients with St-LBBB (p<0.01), with the group of NICM exhibiting the greatest benefit (p<0.01). St-LBBB CRT responders displayed significantly lower rates of HF hospitalization (p<0.0001) compared to non-St-LBBB group. This was mostly evident in patients with NICM (p<0.0001) according to Kaplan-Meier time curves. CRT responders displayed significantly fewer VA events (p<0.001) and lower mortality rates (p<0.0001) than non-responders. Kaplan-Meier estimates demonstrated a significantly lower incidence of VAs in NICM patients with St-LBBB (p:0.049) in comparison to ICM patients with St-LBBB (p:0.25). Lower mortality rates were observed in CRT responders than non-responders (p<0.0001) with the group of NICM with St-LBBB criteria exhibiting the greatest benefit (p:0.0238). Conclusions: Patients with NICM and St-LBBB present the greatest benefit with respect to CRT response, HF hospitalizations, VA events, and mortality. St-LBBB criteria may improve patient selection for CRT.